NL1001012C2 - Antibioticum WAP-8294A, werkwijze voor de bereiding daarvan alsmede antibacteriële samenstelling. - Google Patents

Antibioticum WAP-8294A, werkwijze voor de bereiding daarvan alsmede antibacteriële samenstelling. Download PDF

Info

Publication number
NL1001012C2
NL1001012C2 NL1001012A NL1001012A NL1001012C2 NL 1001012 C2 NL1001012 C2 NL 1001012C2 NL 1001012 A NL1001012 A NL 1001012A NL 1001012 A NL1001012 A NL 1001012A NL 1001012 C2 NL1001012 C2 NL 1001012C2
Authority
NL
Netherlands
Prior art keywords
mol
acid
wap
minutes
absorption spectrum
Prior art date
Application number
NL1001012A
Other languages
English (en)
Dutch (nl)
Other versions
NL1001012A1 (nl
Inventor
Makoto Maeda
Yoshitami Ohashi
Haruhisa Hirata
Seigo Nakaya
Azusa Katou
Yuji Aiba
Naomi Kokubo
Nobuyuki Suzuki
Original Assignee
Wakamoto Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP01604495A external-priority patent/JP3339235B2/ja
Application filed by Wakamoto Pharma Co Ltd filed Critical Wakamoto Pharma Co Ltd
Publication of NL1001012A1 publication Critical patent/NL1001012A1/xx
Application granted granted Critical
Publication of NL1001012C2 publication Critical patent/NL1001012C2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NL1001012A 1995-02-02 1995-08-18 Antibioticum WAP-8294A, werkwijze voor de bereiding daarvan alsmede antibacteriële samenstelling. NL1001012C2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1604495 1995-02-02
JP01604495A JP3339235B2 (ja) 1994-02-18 1995-02-02 抗生物質ｗａｐ−８２９４ａ、その製造法及び抗菌剤

Publications (2)

Publication Number Publication Date
NL1001012A1 NL1001012A1 (nl) 1996-08-21
NL1001012C2 true NL1001012C2 (nl) 1998-09-01

Family

ID=11905579

Family Applications (1)

Application Number Title Priority Date Filing Date
NL1001012A NL1001012C2 (nl) 1995-02-02 1995-08-18 Antibioticum WAP-8294A, werkwijze voor de bereiding daarvan alsmede antibacteriële samenstelling.

Country Status (6)

Country Link
KR (1) KR100225601B1 (zh)
CN (2) CN1080310C (zh)
AU (1) AU705610B2 (zh)
HK (1) HK1046155B (zh)
HU (1) HU218351B (zh)
NL (1) NL1001012C2 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1292663C (zh) * 2005-10-21 2007-01-03 云南农业大学 一种防治植物细菌病害的生物制剂及其应用
CA2656604C (en) * 2006-06-29 2014-01-07 Arigen Pharmaceuticals, Inc. Injectable formulation of antibiotic and solution for intravenous administration thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588588A (en) * 1983-12-05 1986-05-13 E. R. Squibb & Sons, Inc. Antibiotic EM5487
EP0196042A2 (en) * 1985-03-25 1986-10-01 E.R. SQUIBB & SONS, INC. Antibiotic prepared from lysobacter sp. SC 14,067

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588588A (en) * 1983-12-05 1986-05-13 E. R. Squibb & Sons, Inc. Antibiotic EM5487
EP0196042A2 (en) * 1985-03-25 1986-10-01 E.R. SQUIBB & SONS, INC. Antibiotic prepared from lysobacter sp. SC 14,067

Also Published As

Publication number Publication date
HU218351B (hu) 2000-08-28
CN1080310C (zh) 2002-03-06
KR100225601B1 (ko) 1999-10-15
KR960030942A (ko) 1996-09-17
CN1132252A (zh) 1996-10-02
AU705610B2 (en) 1999-05-27
CN1196794C (zh) 2005-04-13
AU3012695A (en) 1996-08-08
HK1046155B (zh) 2005-09-30
HUT72397A (en) 1996-04-29
NL1001012A1 (nl) 1996-08-21
HU9502434D0 (en) 1995-10-30
CN1357631A (zh) 2002-07-10
HK1046155A1 (en) 2002-12-27

Similar Documents

Publication Publication Date Title
JPH035398B2 (zh)
JP2873340B2 (ja) 抗生物質ｔａｎ―１０５７，その製造法および用途
KR960013432B1 (ko) 항균제 fr109615 및 이의 제조방법
NL7907191A (nl) Antibioticum sb-72310.
CA2142638C (en) Antibiotic wap-8294a, method for preparing the same and antibacterial composition
US4409210A (en) Antibiotic compound
JPH07233165A (ja) 新規抗真菌化合物
NL1001012C2 (nl) Antibioticum WAP-8294A, werkwijze voor de bereiding daarvan alsmede antibacteriële samenstelling.
FI100112B (fi) Menetelmä bakteerien vastaisen tiomarinolin valmistamiseksi
US4575489A (en) Streptomyces albulus subsp. ochragerus subsp. nov. culture for making peptide
US4533631A (en) Fermentation process for preparation of antibiotic Bu-2517
JP3036923B2 (ja) デプシペプチドａ、ｂその製造方法、並びに抗ウイルス剤及び抗菌剤
JP2863934B2 (ja) 抗生物質プラスバシン
JP2640932B2 (ja) Ｔａｎ−８６６、その製造法および微生物
JP2003113192A (ja) 抗生物質ｗａｐ−２６０７ｂ、その製造法及び抗菌剤
KR820000513B1 (ko) β-락타마제 저지활성을 갖는 항생물질 유도체의 제조방법
EP0024206A2 (en) Antitumor substance, composition comprising it and process for preparing said substance
JPH0430400B2 (zh)
JP3123864B2 (ja) 新規化合物チオマリノールｃおよびその製造法
RU2089548C1 (ru) Тиомаринол c и способ его получения
JPS62258394A (ja) 抗生物質ｔａｎ−７４９，その製造法およびそれを含有する細菌感染症治療剤
JPH07291992A (ja) 新規化合物ｂ４３１７
JPH0578355A (ja) Ｂ−１０１５化合物
JPS6029476B2 (ja) シトフアギンおよびその製造法
JPH0566111B2 (zh)

Legal Events

Date Code Title Description
AD1A A request for search or an international type search has been filed
RD2N Patents in respect of which a decision has been taken or a report has been made (novelty report)

Effective date: 19980427

PD2B A search report has been drawn up
SD Assignments of patents

Owner name: NIPPON MEDICAL RESEARCH, INC.

SD Assignments of patents

Owner name: ARIGEN, INC.

TD Modifications of names of proprietors of patents

Owner name: ARIGEN PHARMACEUTICALS, INC.

Effective date: 20071218

SD Assignments of patents

Effective date: 20130625

SD Assignments of patents

Effective date: 20150403

SD Assignments of patents

Effective date: 20150403

V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20150818